45E:FRA
Natera Inc
€280.80
arrow_upward
+0.86%(+2.40) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 45E...
Open
€280.80
High
€280.80
Low
€280.80
Mkt. cap
47.31B
Avg. vol.
9.00
Volume
0.00
52-wk high
€291.00
52-wk low
€158.00
No. of employees
6K
Open
€280.80
High
€280.80
Low
€280.80
Mkt. cap
47.31B
Avg. vol.
9.00
Volume
0.00
52-wk high
€291.00
52-wk low
€158.00
No. of employees
6K
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com